{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:33:39Z","timestamp":1784604819812,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.clcc.2021.05.005","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T08:59:12Z","timestamp":1621846752000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO)"],"prefix":"10.1016","volume":"20","author":[{"given":"Bruna R.S.","family":"Mattos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos P.G.","family":"Camandaroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ruiz-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Diaz-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara K.F.","family":"Lustosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinara F.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso A.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Riechelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2021.05.005_bib0001","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2021.05.005_bib0002","unstructured":"World Health Organization. International Agency for Research on Cancer [http:\/\/gco.iarc.fr] Date accessed: 19\/01\/2021."},{"key":"10.1016\/j.clcc.2021.05.005_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.soc.2016.07.001","article-title":"Epidemiology of anal canal cancer","volume":"26","author":"Nelson","year":"2017","journal-title":"Surg Oncol Clin North Am"},{"key":"10.1016\/j.clcc.2021.05.005_bib0004","doi-asserted-by":"crossref","unstructured":"Johnson L.G., Madeleine M.M., Newcomer L.M., et\u00a0al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000Cancer 101(2) 281\u2013288.","DOI":"10.1002\/cncr.20364"},{"key":"10.1016\/j.clcc.2021.05.005_bib0005","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1037","article-title":"Anal Canal Cancer in Brazil: Why Should We Pay More Attention to the Epidemiology of This Rare Disease?","author":"Donadio","year":"2020","journal-title":"Ecancer"},{"issue":"7","key":"10.1016\/j.clcc.2021.05.005_bib0006","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.clcc.2021.05.005_bib0007","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24215","article-title":"Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions","volume":"124","author":"Hoots","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2021.05.005_bib0008","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.clcc.2021.05.005_bib0009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.clcc.2021.05.005_bib0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2021.05.005_bib0011","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","article-title":"Anal cancer: an overview","volume":"12","author":"Uronis","year":"2007","journal-title":"Oncologist"},{"issue":"124","key":"10.1016\/j.clcc.2021.05.005_bib0012","first-page":"1626","article-title":"Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2021.05.005_bib0013","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0959-8049(00)00009-5","article-title":"Treatment of HIV associated invasive anal cancer with combined chemoradiation","volume":"36","author":"Cleator","year":"2000","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.clcc.2021.05.005_bib0014","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(18)30321-8","article-title":"Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2021.05.005_bib0015","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1200\/JCO.19.03266","article-title":"International rare cancers initiative multicenter randomized phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct","volume":"38","author":"Rao","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2021.05.005_bib0016","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COC.0000000000000172","article-title":"Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal","volume":"40","author":"White","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clcc.2021.05.005_bib0017","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/BF02234605","article-title":"HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients","volume":"44","author":"Kim","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2021.05.005_bib0018","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","article-title":"Invasive anal squamous-cell carcinoma in the HIV-positive patient: Outcome in the era of highly active antiretroviral therapy","volume":"51","author":"Wexler","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2021.05.005_bib0019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/jgo.2018.10.08","article-title":"Treatment outcomes of patients with localized anal squamous cell carcinoma according to HIV infection: systematic review and meta-analysis","volume":"10","author":"Camandaroba","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2021.05.005_bib0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1200\/JCO.2007.14.2810","article-title":"Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era","volume":"26","author":"Chiao","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2021.05.005_bib0021","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(17)30104-3","article-title":"Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicenter, single-arm, phase 2 study","volume":"18","author":"Morris","year":"2017","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.clcc.2021.05.005_bib0022","article-title":"Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair\u2013Deficient Cancer: Results From the Phase II KEYNOTE-158 Study","author":"Marabelle","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.clcc.2021.05.005_bib0023","first-page":"10","article-title":"Immunotherapy in People With HIV and Cancer","author":"Puronen","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.clcc.2021.05.005_bib0024","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamaoncol.2018.6737","article-title":"Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: a systematic review","volume":"5","author":"Cook","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002821000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002821000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:07:08Z","timestamp":1761520028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002821000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1533002821000475"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2021.05.005","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO)","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2021.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}